Hasil Pencarian  ::  Simpan CSV :: Kembali

"Tujuan : Mengetahui peranan NAC sebagai proteksi terjadinya penurunan fungsi ginjal pada penderita yang menjalani operasi BP AK Latar Belakang : Gangguan ginjal akut (GgGA) merupakan salah satu penyebab utama morbiditas dan mortalitas pada pasien-pasien yang menjalani operasi bedah pintas arteri koroner (BP AK). Penurunan fungsi ginjal yang terjadi paska operasi jan tung bersifat multifaktoral antara lain : instabilitas hemodinamik perioperatif, gangguan perfusi ginjal, gangguan iskemia reperfusi, dan teraktivasinya jalur inflamasi yang pada akhirnya menimbulkan nekrosis tubular akuL Intervensi fannakologis dengan pemberian N-asetilsistein (NAC) sebagai profilaksis GgGA paska operasi BP AK masih banyak diperdebatkan. Namun efikasi NAC cukup menjanjikan sebagai profilaksis GgGA paska operasi berkaitan dengan efek vasodilator dan anti oksidan yang poten. Metode : Penelitian ini merupakan percobaan klinik tersamar tunggal dengan randomisasi (Randomized clinical trial = RC1) pada penderita yang menjalani operasi BPAK di Departemen Kardiologi dan Kedokteran Vaskular FKUII PJNHK. dari bulan Mei 2011 sampai dengan bulan Agustus 2011 yang mernnuhi kriteria penerimaan. Subjek penelitian dibagi menjadi dua kelompok antara kelompok perlakuan (NAC) yang mendapat NAC sebelum dan sesudah operasi BP AK dan kelompok kontrol. Dilakukan penghitungan nilai rerata dan simbang baku maupun nilai median hila sebaran data tidak normal. Pengujian kemaknaan statistik dilakukan dengan uji Student t bagi hubungan antara variabel kualitatif dan kuantitatif. Hubungan antara dua variabel kualitatif diuji dengan Chi Square test. Pengambilan kesimpulan statistik didasarkan pada batas kemaknaan sebesar < 0.05. Hasil : Dari 124 subjek yang berpartisipasi pada studi ini, angka kejadian GgGA didapatkan sebanyak 27 subjek (21.8%). NAC yang diberikan pada kelompok perlakuan temyata hanya bermanfaat secara bermakna menurunkan risiko GgGA selama 6 jam paska operasi (RIFLE- Risk) dibandingkan dengan kelompok kontrol masing-masing dengan 5 (8 .1%) vs 18 (29.0%), P= 0.003 . Selanjutnya selama pengamatan penurunan fungsi ginjal dalam 12 jam (RIFLE-Injury) sampai 48 jam (RIFLE-Failure) tidak ditemukan adanya perbedaan yang bermakna antara kelompok perlakuan dengan kelompok kontrol masing-masing dengan 4 (6.5%) vs 3 (4.8%), P= 1.000 dan 4 (6.5%) vs 1 (1.6%), P= 0.365.

---

Aim of the study : To analyze the role ofN- Acetylcysteine (NAC) as the prophylaxis against Acute kidney injury (AKI) in patients after coronary artery bypass graft (CABG) surgery. Background : AKI is one of the most common cause of morbidity and mortality in patients who underwent CABG. AKI following CABG had multifactoral causes namely : perioperative haemodynamic instability, renal perfusion mismatch, ischemia reperfusion injury, and activation of inflammation pathway which consequently causing acute tubular necrosis. Pharmacological intervention by the administration of NAC as the prophylaxis of AKI following CABG surgery was still the matter of controversy. However, it's still promising regarding its own efficacy as vasodilator and potential anti oxidant Methode : A prospective randomized clinical trial, placebo-controlled, singl~blind study was conducted in patients who underwent CABG surgery at the Department Of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia/ National Cardiovascular Centre Harapan Kita Jakarta from May 2011 until August 2011. After being approved by the local ethic committee and written informed consents, subjects were randomly assigned to receive NAC before and after surgery or placebo. All data were analyzed with the calculation of either mean and standard deviation or median whenever abnormal variance was noted. Statistical analyze was performed with Student t test to qualitative and quantitative variables. The association of two qualitative variables was analyzed using Chi Square test. Statistical conclusion was based on the P value ofless than 0.05 Result : There were 124 subjects participating in this study. The incidence of AKI was found in 27 (21.8%) subjects. NAC only showed significantly efficacious in reducing AKI within 6 hours after CABG (RIFLE- Risk) with 5 (8.1 %) subjects with NAC vs 18 (29.0%) subjects with placebo consecutively with P value 0.003. Further observation in the presence of AKI within 12 hours (RIFLE-Injury) till24 hours post operative (RIFLE-Failure) showed no significant difference between NAC and placebo with 4 (6.5%) patients vs 3 (4.8%) patients with P= 1.000 and 4 (6.5%) patients vs 1 (1.6%) with P = 0.365 consecutively. Conclusion : The administration of NAC did not significantly prevent AKI following CABG surgery but only lowered the risk of AKI within 6 hours post operative (RIFLE-R)"

"Latar belakang: Gagal ginjal akut (GGA) menjadi salah satu komplikasi serius yang dapat terjadi setelah prosedur bedah pintas arteri koroner (BPAK). GGA paskaoperasi jantung secara independen berhubungan dengan peningkatan 3-8 kali lipat angka morbiditas dan mortalitas serta memperpanjang durasi perawatan (hospitalisasi) sehingga dapat meningkatkan biaya kesehatan. Untuk menurunkan insidensi GGA ini, dibutuhkan modalitas pemeriksaan sebelum operasi yang berhubungan dengan kejadian GGA paska BPAK sehingga dapat digunakan sebagai prediktor nantinya untuk tindakan pencegahan. Indeks resistif renal (IRR) diketahui dapat menggambarkan kondisi resistensi dan komplians pembuluh darah yang berhubungan dengan patofisiologi GGA paska BPAK. Namun hingga saat ini belum ada penelitian yang menilai hubungan langsung antara nilai IRR dan kejadian GGA paska BPAK. Tujuan: Mengetahui hubungan nilai IRR terhadap kejadian GGA paska BPAK Metode: Pasien yang akan dilakukan prosedur BPAK akan menjalani pemeriksaan dupleks renalis untuk mendapatkan nilai IRR. Luaran gagal ginjal akut dinilai dengan pemeriksaan kadar kreatinin darah selama 48 jam paska BPAK Hasil: Terdapat 96 pasien yang menjadi subjek penelitian. Median nilai IRR pada subjek penelitian ini ialah 0.71 (0.57-0.87). Terdapat perbedaan median nilai IRR antara kelompok GGA dan non GGA (0.73, rentang 0.57-0.87 dan 0.65, rentang 0.58-0.72). Nilai IRR memiliki korelasi yang cukup baik terhadap kejadian GGA paska BPAK (nilai koefisien korelasi r = 0.66, p < 0,001) dengan titik potong padanilai IRR 0.685 (sensitivitas 82.40%, spesifisitas 73.30%). Faktor-faktor lain seperti usia, diabetes melitus, hipertensi, nilai kreatinin serum pre operatif, klirens kreatinin pre operatif, fraksi ejeksi, durasi mesin pintas kardiopulmonal dan durasi klem silang aorta secara statistika berbeda bermakna berhubungan terhadap kejadian GGA paska BPAK. Namun dari analisis multivariat, hanya faktor fraksi ejeksi, durasi mesin pintas kardiopulmonal, nilai IRR, dan diabetes mellitus terbukti bermakna Kesimpulan: Terdapat hubungan antara IRR dengan kejadian gagal ginjal akut paska BPAK. Nilai IRR 0.685 merupakan titik potong optimal (sensitivitas 82,40% dan spesifisitas 73.30%)

---

Background: Acute kidney injury (AKI) still become one of the serious complications that can occur after a coronary artery bypass graft (CABG) procedure. Post-operative AKI is independently associated with a 3-8 fold increase in morbidity and mortality and extending the duration of treatment (hospitalization) thereby increasing health costs. To reduce the incidence of AKI, a modality of examination prior surgery which is related to the incidence of post-operative AKI is needed so that it can be used as a predictor later for preventive action. The renal resistive index (RRI) is known to be able to describe the condition of resistance and vascular compliance which are related to the pathophysiology of post-operative AKI. However, there has been no research that assesses the direct relationship between RRI values and the incidence of post-operative AKI Objectives: To investigate the relationship between RRI value and incidence of post-operative AKI in patients underwent CABG procedure. Methods: CABG candidates patients will undergo duplex renalis examination to obtain an RRI score. Outcome of renal impairment was assessed by blood creatinine examination within 48 hours after CABG procedure. Results: There were 96 patients who became the subject of the study. The median of RRI value in this study subjects was 0.71 (0.57-0.87). There were differences in median of RRI values between groups with post-operative AKI and those not (0.73, range 0.57-0.87 dan 0.65, range 0.58-0.72). There was quite good correlation between RRI and post-operative AKI (p < 0.001 with correlation coefficient r = 0.66) with cut off point of IRR value was 0.685 (sensitivity 82.40%, specificity 73.30%). Other factors such as age, diabetes mellitus, hypertension, ejection fraction, CPB duration, and aortic cross clamp duration are associated with incidence of post-operative AKI. However, multivariat analysis showed only ejection fraction, cardiopulmonary bypass duration, RRI, and diabetes mellitus significantly related to post-operative AKI Conclusion: RRI values has relationship with post-operative AKI. The optimal cut off value of RRI retrieved by this study is 0.685 (sensitivity 82.40%, specificity 73.30%)"

"Latar belakang : Konduit vena lebih rentan mengalami trombosis dini dalam satu tahun pertama pasca bedah pintas arteri koroner sehingga meningkatkan risiko morbiditas maupun mortalitas. Penelitian ini bertujuan untuk meneliti ada tidaknya perbedaan kejadian trombosis dini konduit vena pascabedah pintas arteri koroner (BPAK) dengan teknik on-pump dan off-pump pada pasien non-resisten aspirin.Metode : Dilakukan suatu studi kohort prospektif pada pasien yang menjalani operasi BPAK elektif di Rumah Sakit Jantung dan Pembuluh Darah Harapan Kita dari bulan September 2019 hingga September 2020. Penelitan ini membandingkan kejadian trombosis pada satu bulan pascabedah pada kelompok on-pump dan off-pump dengan menggunakan pemeriksaan MSCT, serta membandingkan nilai MGF dan PI pada kedua kelompok tersebut.Hasil : Sebanyak 60 konduit vena dari 28 pasien yang menjalani BPAK dilibatkan dalam penelitian ini. Sebanyak masing-masing 30 konduit pada kelompok off-pump dan on-pump. Hasil penelitian ini menunjukan tidak ada perbedaan bermakna pada kejadian trombosis dini antara kedua kelompok. Kejadian trombosis dini pada BPAK on-pump sebanyak 13,3% dan pada BPAK off-pump 13,3% (p=1). Evaluasi nilai MGF dan PI juga menunjukan hasil tidak berbeda bermakna antara kedua teknik operasi maupun pada kelompok konduit yang paten atau oklusi.Simpulan : Tidak ada perbedaan bermakna pada kejadian trombosis dini antara BPAK baik secara on pump maupun off pump

---

Introduction : Early thrombosis is more common in vein grafts and may occur within the first year after coronary artery bypass graft surgery and can increase morbidity and mortality rate. This study aims to establish whether there is a difference of the incidence of early thrombosis after on-pump and off-pump CABG in non-aspirin resistant patient population.

Method : Patients who undergone elective CABG surgery from September 2019 to September 2020 in single center was included in this prospective cohort study. This study compares the incidence of vein graft thrombosis at one month postoperative in both groups on pump and off pump using MSCT, and compares MGF and PI value of in on pump and off pump group also in patent and occluded vein grafts.

Results : A total of 60 vein grafts (30 on-pump and 30 off-pump) from 28 patients were analyzed in this study. There was no significant difference on the incidence of early vein graft thrombosis between two groups (13,3% in on pump vs 13,3% in off pump, p:1). MGF and PI value showed no difference in both techniques also no difference in patent group and occluded group

Conclusion : There is no significant difference in early vein graft thrombosis after on-pump or off-pump CABG."

"Penyakit jantung koroner (PJK) menyebabkan ketidakseimbangan suplai dan kebutuhan metabolik miokard dalam melakukan fungsi sirkulasi dan homeostasis. Baku emas terapi PJK adalah bedah pintas arteri koroner (BPAK). Prosedur BPAK dengan mesin pintas jantung paru (PJP) dapat mencetuskan cedera miokard tingkat selular sehingga memerlukan aplikasi proteksi miokard. Glutamin adalah asam amino conditionally essential yang berperan dalam proteksi miokard dengan membentuk energi selama periode iskemia, tetapi belum teruji penggunaannya pada pasien dengan fraksi ejeksi rendah. Padahal, pasien fraksi ejeksi (EF) rendah lebih rentan terhadap cedera miokard, sehingga glutamin diharapkan dapat memberi proteksi. Penelitian menggunakan desain double blind randomized controlled trial di Instalasi Bedah Jantung Dewasa RSJPDHK Jakarta pada bulan Januari–Agustus 2021 dengan subjek penelitian 60 pasien sesuai kriteria inklusi dan eksklusi. Alokasi random subjek untuk memilih 30 pasien mendapatkan 500 mL glutamin 0,5 g/kg dalam NaCl 0,9% sebagai kelompok intervensi (glutamin), dan 30 pasien mendapatkan NaCl 0,9% sebanyak 500 mL sebagai kelompok kontrol selama 24 jam pertama. Pengukuran yang dilakukan meliputi kadar glutamin plasma, kadar α-KG, myocardial injury score, indeks apoptosis, ekspresi anti-kardiak troponin I, kadar troponin I, EF, indeks jantung dan kadar laktat. Dua subjek drop out sehingga analisis dilakukan terhadap 58 subjek. Efek proteksi miokard glutamin terlihat pada kadar troponin I, laktat plasma, dan myocardical injury score yang lebih rendah pada kelompok glutamin, serta ekspresi anti-kardiak troponin I jaringan apendiks atrium kanan jantung setelah mesin PJP dilepas lebih tinggi dibandingkan kontrol. Tidak didapatkan perbedaan bermakna indeks apoptosis jaringan apendiks atrium kanan, fraksi ejeksi pasca-operasi, penggunaan vasoaktif dan inotropik pasca-operasi, durasi penggunaan ventilator dan durasi perawatan intensif pasca-operasi pada kedua kelompok. Simpulan: Pemberian preoperatif glutamin 0,5 g/kg secara intravena dalam 24 jam pertama memiliki efek proteksi miokard pada pasien BPAK elektif dengan EF rendah yang menggunakan mesin PJP.

---

Coronary heart disease (CHD) causes a myocardial metabolic supply and demand imbalance in performing circulatory and homeostatic functions. The gold standard treatment of CHD is coronary artery bypass graft (CABG). The CABG procedure with a cardiopulmonary bypass (CPB) machine can trigger myocardial injury at cellular level due to ischemia and reperfusion. Glutamine is a conditionally essential amino acid in the human body which has a role as myocardial protector through energy production during myocardial ischemia. However, its application has not been tested in low ejection fraction (EF) patients. Meanwhile, patients with low EF are more vulnerable to myocardial injury. Thus, glutamine administration was expected to provide myocardial protection. The study was a double-blind, randomized controlled trial design and was performed at the Adult Cardiac Surgery Installation of the National Cardiovascular Center Harapan Kita, Jakarta from January to August 2021 with a sample size of 60 patients meeting the inclusion and exclusion criteria. Subjects were randomly allocated into intervention (glutamine): 30 patients were administered a solution of glutamine 0.5 g/kg dissolved in 0.9% NaCl up to 500 mL in total volume and control group; 30 patients were administered 500 mL of 0.9% NaCl, both over a period of the first 24 hours. Parameters measured include plasma glutamine levels, α-KG levels, myocardial injury scores, apoptotic index, anti-cardiac troponin I expression, troponin I levels, EF, cardiac index and lactate levels. Two samples were dropped out; hence 58 patients were analyzed in this study. Myocardial protective effects of glutamine are observed in plasma troponin I, lactate levels, and myocardial injury score of right atrial appendage tissue, which were significantly lower in the glutamine group and higher anti-cardiac troponin I expression of right atrial appendage tissue in the glutamine group. Apoptotic index of right atrial appendage tissue, postoperative ejection fraction, postoperative use of vasoactive and inotropic, ventilator time, and duration of intensive care showed no significant differences in both groups. Conclusion: Preoperative administration of intravenous glutamine 0.5 g/kg in the first 24 hours has a cardioprotective effect in low EF patients underwent elective on-pump CABG."

"Pendahuluan: Pasien pasca Bedah Pintas Arteri Koroner (BPAK) dapat mengalami penurunan kapasitas fungsional dan produktivitas. Hal ini dikarenakan adanya penurunan curah jantung dan penghancuran protein otot (aktin dan miosin). Latihan berjalan dilakukan untuk meningkatkan pompa jantung dan keseimbangan metabolisme. Penelitian ini bertujuan untuk menilai pengaruh latihan berjalan terhadap kapasitas fungsional dan produktivitas ada pasien pasca BPAK. Metode: Penelitian ini menggunakan Randomized Controlled Trial (RCT) dengan single blind pada outcome assessor. Jumlah responden pada penelitian ini berjumlah 42 orang yang dibagi menjadi 21 orang di kelompok intervensi maupun kontrol. Hasil: Penelitian ini menunjukkan hasil adanya pengaruh yang bermakna antara latihan berjalan terhadap kapasitas fungsional (0,008<0,05), gangguan dalam bekerja (0,011<0,05), dan gangguan aktivitas(0,044<0,05). Hasil juga menunjukkan tidak adanya perbedaan yang bermakna antara latihan berjalan terhadap kehilangan waktu kerja (0,967>0,05) dan gangguan pekerjaan keseluruhan (0,696). Diskusi: Latihan berjalan meningkatkan pompa jantung dan metabolisme. hal tersebut meningkatkan pengeluaran Adenosine Triphospat (ATP) sehingga meningkatkan kapasitas fungsional dan produktivitas pada pasien. Kesimpulan: Latihan berjalan meningkatkan kapasitas fungsional dan produktivitas pada pasien pasca BPAK.

---

Introduction: Patients after coronary artery bypass graft (CABG) may experience reduced functional capacity and productivity. This is due to decreased cardiac output and destruction of muscle proteins (actin and myosin). Walking exercise is performed to improve cardiac pump and metabolic balance. This study aims to assess the effect of walking training on functional capacity and productivity in patients after BPAK.

Methods: This study used a Randomized Controlled Trial (RCT) with a single blind on the outcome assessor. The number of respondents in this study amounted to 42 people who were divided into 21 people in the intervention and control groups.

Results: This study showed a significant effect of walking training on functional capacity(0,008<0,05), work interference(0,011<0,05), and activity interference(0,044<0,05). The results also showed no significant difference between walking training on lost work time (0,967>0,05)and overall work interference(0,696>0,05).

Discussion: Walking exercise improves cardiac pump and metabolism, which increases Adenosine Triphosphate (ATP) expenditure, thereby improving functional capacity and productivity in patients.

Conclusion: Walking exercise improves functional capacity and productivity in patients after BPAK."

"Latar Belakang: Penyakit arteri koroner dapat di tata laksana dengan bedah pintas arteri koroner (BPAK) menggunakan mesin pintas jantung paru (PJP) dan fraksi ejeksi (FE) yang rendah berhubungan dengan peningkatan mortalitas jangka pendek dan jangka panjang. Kejadian AKI pascaoperasi BPAK dengan mesin PJP merupakan kejadian yang cukup sering dengan prevalensi bervariasi antara 7,6-48,5%. Patogenesis acute kidney injury(AKI) pascaoperasi jantung bersifat kompleks dan multifaktorial, dengan beberapa mekanismenya melibatkan proses inflamasi, iskemia-cedera reperfusi, dan stres oksidatif. Hingga saat ini belum ada pedoman strategi proteksi ginjal pada operasi BPAK. Glutamin, sebuah asam amino esensial-kondisional memiliki efek anti inflamasi dan anti oksidena melalui induksi heat shock protein (HSP) dan produksi antioksidan glutathione (GSH). Sehingga, dihipotesiskan pemberian glutamin dapat menurunkan kejadian AKI menurunkan gangguan fungsi ginjal pascaoperasi BPAK.Metodologi: Penelitian ini merupakan penelitian kohort retrospektif pada pasien yang menjalani operasi BPAK menggunakan mesin PJP dengan FE rendah. Subjek dibagi menjadi kelompok yang mendapat glutamin intravena praoperasi dan kelompok yang tidak mendapat glutamin. Kejadian AKI 24 jam pascaoperasi, kadar kreatinin serum 24 jam pascaoperasi dan estimated glomerular filtration rate(eGFR) 24 jam pascaoperasi merupakan luaran yang dinilai pada penelitian ini.Hasil: Dari hasil penelitian didapatkan kejadian AKI 24 jam pascoperasi pada kelompok glutamin sebesar 3,3% dan kelompok kontrol 10%. Namun, tidak didapatkan hubungan bermakan kejadian AKI 24 jam pascaoperasi terhadap pemberian glutamin intravena praoperasi (p=0,612). Dari hasil pemeriksaan eGFR 24 jam pascaoperasi, didapatkan rerata kelompok kontrol 57,67 ± 18,86 mL/min/1,73m2dan kelompok glutamin 64,43 ± 17,56 mL/min/1,73m2, namun tidak berbeda bermakna (p=0,156). Dari hasil pemeriksaann kreatinin serum 24 jam pascaoperasi, didapatkan median kelompok kontrol 1,3 (0,87 – 2,68) mg/dL dan kelompok glutamin 1,2 (0,78 – 2,35), namun hasil ini juga tidak berbeda bermakna (p=0,258)Kesimpulan: Pemberian glutamin intravena praoperasi pada pasien dengan fraksi ejeksi rendah yang menjalani BPAK menggunakan mesin PJP, tidak memiliki hubunga bermakna terhadap kejadian AKI dan eGFR serta kadar kreatinin serum 24 jam pascaoperasi.

---

Background: Coronary artery disease can be managed by coronary artery bypass graft surgery (CABG) using a cardiopulmonary machine (CPB) and low ejection fraction (FE) is associated with increased short-term and long-term mortality. The incidence of postoperative acute kidney injury (AKI) after CABG using a CPB machine is quite common with a prevalence varying between 7.6-48.5%. The pathogenesis AKI after cardiac surgery is complex and multifactorial, with several mechanisms involving inflammation, ischemia-reperfusion injury, and oxidative stress. Until now, there are no guidelines for kidney protection strategies in CABG surgery. Glutamine, a conditionally essential amino acid has anti-inflammatory and anti-oxidant effects through the induction of heat shock protein (HSP) and the production of the antioxidant glutathione (GSH). Thus, it is hypothesized that the administration of glutamine can reduce the incidence of AKI and decrease renal function impairment after CABG surgery.

Methods: This study is a retrospective cohort study in patients who underwent CPA surgery using a PJP machine with low FE. Subjects were divided into groups that received preoperative intravenous glutamine and groups that did not receive glutamine. The incidence of AKI 24 hours postoperatively, serum creatinine levels 24 hours postoperatively and the estimated glomerular filtration rate (eGFR) 24 hours postoperatively were the outcomes assessed in this study.

Results:From this study, the incidence of AKI 24 hours postoperatively in the glutamine group was 3.3% and the control group was 10%. However, there was no significant relationship between the incidence of AKI 24 hours postoperatively with preoperative intravenous glutamine administration (p=0.612). From the results of the 24-hour postoperative eGFR examination, the mean of the control group was 57.67 ± 18.86 mL/min/1.73m2 and the glutamine group was 64.43 ± 17.56 mL/min/1.73m2, but not significantly different (p= 0.156). From the results of serum creatinine examination 24 hours postoperatively, the median control group was 1.3 (0.87 – 2.68) mg/dL and the glutamine group 1.2 (0.78 – 2.35) mg/dL, but these results also did not differ significantly (p=0,258)"

"Latar Belakang: Pasien dengan fraksi ejeksi (FE) rendah memiliki risiko apabila dilakukan BPAK dengan mesin PJP. Pengunaan mesin PJP memiliki risiko cedera miokard yang diakibatkan dari periode iskemia, reperfusi, dan inflamasi yang dapat mengakibatkan aritmia pascaoperasi. Aritmia pascaoperasi BPAK terjadi pada 5-40% dan meningkatkan mortalitas serta morbiditas. Glutamin merupakan asam amino yang memiliki efek anti inflamasi dengan menurunkan mediator inflamasi dan kerusakan oksidatif akibat radikal bebas sehingga menurunkan efek cedera miokard dan dihipotesiskan menurunkan kejadian aritmia pascaoperasi BPAK. Metodologi: Penelitian ini kohort retrospektif pada pasien penyakit jantung koroner dengan FE rendah yang menjalani BPAK menggunakan mesin PJP. Subjek dibagi menjadi kelompok yang mendapat dan tidak mendapat glutamin intravena praoperasi. Luaran yang dinilai adalah kejadian aritmia pascaoperasi secara keseluruhan, arimita ventrikel dan supraventrikel pascaoperasi BPAK. Hasil: Kejadian aritmia pascaoperasi lebh rendah secara bermakna pada kelompok yang mendapatkan glutamin intravena praoperasi, yaitu 16,7%dibandingkan 40% (p=0,045). Kejadian aritmia atrium pascaoperasi juga lebih rendah secara bermakna pada kelompok yang mendapat glutamin intravena praoperasi, yaitu 26,7% dibandingkan 73,3% (p=0,026), namun pada kejadian aritmia ventrikel pascaoperasi tidak ada perbedaan bermakna (p=0,74). Kesimpulan: Pada pasien dengan fraksi ejeksi rendah yang menjalani BPAK menggunakan mesin PJP, pemberian glutamin intravena praoperasi dapat menurunkan angka kejadian aritmia pascaoperasi.

---

Background: Low ejection fraction (EF) increases the risk of morbidity and mortality in patients undergoing CABG. CABG with CPB induces myocardial injury caused from ischemia, reperfusion and inflammation, causing postoperative arrhythmias. Arrhyhtmias occur in 5-40% patients after CABG and increase postoperative mortality and morbidity. Glutamine is an amino acid that has antiinflammatory effect, decerasing inflammatory mediators and oxidative stress from free radicals. In turn, glutamin lower the effect of myocardial injury and hypothesized to lower postoperative arrhythmias after CABG.

Methods: This is a cohort retrospective study in patients with coronary artery disease with low EF undergoing CABG with CPB. The subjects were divided into two groups based on given or not given intravenous glutamin preoperative.The outcomes of the study is incidence of arrhythmias after CABG and the incidence of ventricular and supraventricular arrhythmias after CABG.

Results: The subjects in the intravenous glutamin group have lower incidence of postoperative arrhythmias compared to control (16.7% vs 40% respectively, p=0.045). Supraventricular arrhythmia incidence in intravenous glutamin group is also lower compard to control (26.7% vs 73.3% respectively, p=0,026). There are no significant differences of postoperative ventricular arrhythmias between two groups (p=0.74).

Conclussion: In patients with low EF undergoing CABG with CPB, intravenous glutamin administration can lower the incidence of postoperative arrhythmias."

"Latar belakang: Hubungan antara HbA1c dengan kejadian mortalitas dan morbiditas pada pasien diabetes yang menjalani CABG telah dijelaskan dalam banyak penelitian sebelumnya. Namun, peran HbA1c pada populasi pasien non-diabetes dengan PJK yang menjalani BPAK belum pernah dilakukan, khususnya di Indonesia. Penelitian ini bertujuan untuk mengetahui apakah kadar HbA1c praoperasi memiliki hubungan dan dapat memprediksi keluaran awal pascaoperasi setelah BPAK pada pasien non-diabetes dengan penyakit arteri koroner. Metode: Penelitian ini merupakan studi kohort retrospektif pada pasien non-diabetes dengan penyakit jantung koroner yang menjalani BPAK sejak Januari 2022 hingga Desember 2023 di Pusat Jantung Nasional Harapan Kita. Kemudian, data kadar HbA1c praoperasi serta keluaran pascaoperasi yaitu mortalitas intrahospital dan morbiditas pascaoperasi seperti durasi penggunaan ventilator mekanik, lama rawat inap di ICU, lama rawat inap di rumah sakit, Major Adverse Cardiovascular Event (MACE), dan infeksi luka operasi diambil dari rekam medis pasien. Data variabel kontinu dinilai dengan menggunakan uji T atau uji Mann-Whitney U, sedangkan data nominal dinilai menggunakan uji Chi square atau Fischer. Analisis multivariat akan dilakukan lebih lanjut untuk hasil yang signifikan. Hasil: Sebanyak 391 subjek memenuhi kriteria dalam penelitian ini. Usia rata-rata subjek adalah 58,69 ± 8,29 tahun. Subjek dengan prediabetes (n = 268) memiliki perbedaan yang signifikan  secara statistik dalam median durasi ventilator dibandingkan dengan kelompok HbA1c normal (p = 0,009). Namun, tidak didapatkan hubungan yang signifikan antara HbA1c praoperasi dengan mortalitas intrarawat, lama rawat inap di ICU, lama rawat inap di rumah sakit, kejadian MACE, dan infeksi luka operasi pascaoperasi. Simpulan: Tidak terdapat hubungan antara HbA1c praoperasi pada pasien non-diabetes dengan PJK yang telah menjalani BPAK dengan mortalitas intrarawat, lama rawat inap di ICU, lama rawat inap di rumah sakit, kejadian MACE, dan infeksi luka operasi pascaoperasi. Pasien HbA1c normal praoperasi diasosiasikan signifikan secara statistik mempunyai durasi ventilasi mekanik yang lebih pendek dibandingkan pada pasien prediabetes dengan PJK yang telah menjalani BPAK.

---

Background: The association between HbA1c with mortality and morbidity events in diabetic patients undergoing CABG have been explained in many previous studies. However, the predictive value of this in the non-diabetic patient population has not received sufficient attention, especially in Indonesia. This study investigated whether the pre-operative HbA1c level had an association and could predict early post-operative outcomes after CABG in non-diabetic patients with coronary artery disease. Methods: This retrospective cohort study involved non-diabetic patients with coronary artery disease who underwent CABG from January 2022 until December 2023 at National Cardiovascular Center Harapan Kita. Pre-operative HbA1c level and post-operative incidence of intrahospital mortality and morbidities such as mechanical ventilator duration, length of ICU stay, length of hospital stay, major adverse cardiovascular event (MACE), and sternal wound infections were collected. Continuous variable is assessed using T test or Mann- Whitney U test. Nominal data are assessed using Chi square or Fischer test. Multivariate analysis will be conducted further for significant results. Results: Three hundred-ninety-one subjects were involved in this study. The mean age of all subjects was 58.69 ± 8.29 years. Subjects with pre-diabetes (n = 268) have statistically significant difference in median ventilator duration compared to normal HbA1c group (p = 0.009). However, there was no significant association between pre-operative HbA1c and early post-operative intrahospital mortality, length of ICU stay, length of hospital stay, major adverse cardiovascular event (MACE), and sternal wound infections in this population. Conclusion: Pre-operative glycated hemoglobin level is not associated with early mortality, length of ICU stay, length of hospital stay and MACE. However, there is statistically significant lower mechanical ventilator duration in normal HbA1c compared to pre-diabetic patients with CAD who have undergone CABG."

"[Latar belakang : Fibrilasi atrium merupakan aritmia yang paling sering terjadipasca bedah pintas arteri koroner. Peningkatan stress oksidatif, inflamasi, aktivitasneurohormonal memiliki peran terhadap kejadian fibrilasi atrium pasca bedahpintas arteri koroner. Berbagai strategi farmakologis seperti antiaritmia,antiinflamasi, dan antioksidan sudah dipelajari untuk menurun risiko kejadianfibrilasi atrium pasca bedah pintas arteri koroner namun kejadian fibrilasi atriummasih tinggi. Allopurinol memiliki efek antioksidan, namun belum ada uji klinisyang mempelajari efek allopurinol terhadap kejadian fibrilasi atrium. Penelitianini bertujuan untuk menilai efek allopurinol terhadap kejadian fibrilasi atriumpasca bedah pintas arteri koronerMetode : Uji klinis randomisasi tersamar ganda dilakukan di Rumah SakitPembuluh Darah Harapan Kita (RSJPDHK) pada periode April ? Mei 2015.Pasien BPAK on-pump elektif yang diseleksi secara consecutive samplingkemudian dibagi menjadi dua kelompok yaitu kelompok allopurinol dankelompok plasebo dengan randomisasi blok. Subyek diberikan allopurinol 600 mg/ plasebo dosis tunggal sejak 1 hari sebelum operasi sampai hari ke-5 pascaoperasi. Dilakukan pengamatan kejadian fibrilasi atrium pasca operasi sampaipasien pulang dari perawatan.Hasil : Sebanyak 90 subyek diikutsertakan dalam penelitian, 45 subyek padamasing-masing kelompok. Kejadiaan fibrilasi atrium lebih rendah secarabermakna pada kelompok allopurinol (12 (26,7%) vs 22 (48,9%) p 0,030). Kesimpulan : Pemberian allopurinol perioperatif menurunkan kejadian fibrilasi atrium pasca bedah pintas arteri koroner.;Background : Atrial fibrillation is the most common arrhythmias after coronaryartery bypass surgery. Increased oxidative stress, inflammation, neurohormonalactivity has a role on the incidence of atrial fibrillation after coronary arterybypass surgery. Various pharmacological strategies such as antiarrhythmias, antiinflammatory,and antioxidant have been studied to decrease atrial fibrillationincident after coronary artery bypass surgery, but the incidence of atrialfibrillation is still high. Allopurinol has antioxidant effects, but there was noclinical trials that studied the effect of allopurinol on atrial fibrillation incidence.The aim of this study to assess allopurinol effect on the atrial fibrillation incidenceafter coronary artery bypass surgery. Methods: A double-blind randomized clinical trial conducted at the NationalCardiovascular Center Harapan Kita in Jakarta from April to May 2015. Electiveon-pump CABG patients were selected by consecutive sampling then divided intotwo groups: allopurinol and placebo groups with block randomization. Subjectsgiven allopurinol 600 mg / placebo single dose since 1 day before surgery untilthe 5th day post-surgery. The incidence of atrial fibrillation was observedpostoperatively.Results: A total of 90 subjects were included in the study, 45 subjects in eachgroup. Occurrence of atrial fibrillation was significantly lower in the allopurinolgroup (12 (26.7%) vs 22 (48.9%) p 0,030). Conclusion: Perioperative allopurinol reduced the incidence of atrial fibrillation after coronary artery bypass surgery., Background : Atrial fibrillation is the most common arrhythmias after coronaryartery bypass surgery. Increased oxidative stress, inflammation, neurohormonalactivity has a role on the incidence of atrial fibrillation after coronary arterybypass surgery. Various pharmacological strategies such as antiarrhythmias, antiinflammatory,and antioxidant have been studied to decrease atrial fibrillationincident after coronary artery bypass surgery, but the incidence of atrialfibrillation is still high. Allopurinol has antioxidant effects, but there was noclinical trials that studied the effect of allopurinol on atrial fibrillation incidence.The aim of this study to assess allopurinol effect on the atrial fibrillation incidenceafter coronary artery bypass surgery. Methods: A double-blind randomized clinical trial conducted at the NationalCardiovascular Center Harapan Kita in Jakarta from April to May 2015. Electiveon-pump CABG patients were selected by consecutive sampling then divided intotwo groups: allopurinol and placebo groups with block randomization. Subjectsgiven allopurinol 600 mg / placebo single dose since 1 day before surgery untilthe 5th day post-surgery. The incidence of atrial fibrillation was observedpostoperatively.Results: A total of 90 subjects were included in the study, 45 subjects in eachgroup. Occurrence of atrial fibrillation was significantly lower in the allopurinolgroup (12 (26.7%) vs 22 (48.9%) p 0,030). Conclusion: Perioperative allopurinol reduced the incidence of atrial fibrillation after coronary artery bypass surgery.]"

"Latar Belakang: Reperfusi koroner sangat penting untuk menyelamatkan miokardium yang mengalami iskemia namun tindakan ini ternyata juga dapat mengakibatkan cedera miokardium yang dikenal sebagai jejas reperfusi Manifestasi klinisnya berupa komplikasi pasca BPAK diantaranya aritmia penurunan curah jantung dan perioperatif infark miokard Stres oksidatif merupakan salah satu inisiator utama kejadian jejas reperfusi Allopurinol sebagai inhibitor efektif enzim xantin oksidase dapat menurunkan stres oksidatif dengan menghambat pembentukan reactive oxygen species Sehingga diharapkan pemberian allopurinol pada pasien PJK dengan disfungsi ventrikel kiri yang akan menjalani BPAK dapat menurunkan kejadian komplikasi pasca operasiTujuan: Mengetahui efek allopurinol terhadap komplikasi pasca operasi BPAK low cardiac output syndrome yang dinilai dengan penggunaan inotropik dan IABP pasca operasi kematian dalam masa rawat perioperatif infark miokard dan aritmia pada pasien PJK dengan disfungsi ventrikel kiriMetode: Penelitian ini adalah uji klinis tersamar ganda 34 subjek dipilih secara konsekutif pada September November 2015 Subjek dibagi menjadi dua kelompok yaitu 16 orang mendapat allopurinol 600mg dan 18 orang mendapat plasebo Obat per oral diberikan 1 hari sebelum dan 6 jam sebelum operasi Pengamatan kejadian komplikasi pasca operasi dimulai sejak pelepasan klem silang aorta hingga pasien selesai perawatanHasil: Penggunaan inotropik dan IABP pasca operasi menunjukkan perbedaan yang bermakna pada kedua kelompok p 0 047 Ini berarti penggunaan allopurinol berpotensi mengurangi penggunaan inotropik dan IABP pasca operasi BPAK Proporsi kematian dalam masa rawat pasca operasi BPAK pada kedua kelompok tidak berbeda bermakna yaitu 6 25 vs 5 6 p 1 000 Sedangkan untuk kejadian aritmia pada kedua kelompok terdapat perbedaan bermakna dengan total proporsi 31 vs 66 p 0 039 dengan jumlah aritmia terbanyak pada kedua kelompok adalah fibrilasi atrium Kejadian perioperatif infark miokard tidak didapatkan pada penelitian ini sehingga efek pemberian allopurinol terhadap kejadian tersebut tidak dapat dinilaiKesimpulan: Pemberian allopurinol sebelum operasi pada pasien PJK dengan disfungsi ventrikel kiri berpotensi menurunkan kejadian low cardiac output syndrome LCOS yang terlihat dari rendahnya penggunaan obat inotropik dan IABP pasca operasi dan menurunkan kejadian aritmia pasca operasi BPAK

---

Background: Reperfusion of coronary blood flow is important to resuscitate the ischemic or hypoxic myocardium However the return of blood flow to the ischemic area can result paradoxical cardiomyocyte dysfunction this is referred to as ldquo reperfusion injury rdquo Clinical manifestations of reperfusion injury post CABG surgery are arrhythmias decrease cardiac output and perioperative myocardial infarct Oxidative stress has been confirmed as one of the main initiator in myocardial injury at ischemic and reperfusion state Allopurinol as an effective inhibitor of xanthine oxidase XO can reduce the oxidative stress by blocking the formation of reactive oxygen species ROS Pre operative allopurinol on CAD's patient with LV dysfunction is expected reduce the complications of post CABG surgery

Objective: To analyze effects of pre operative administration of allopurinol on complications of post CABG surgery low cardiac output syndrome which is measured by the use of post surgery inotropic and IABP hospital mortality perioperative myocardial infarction and arrhythmias in CAD's patient with LV dysfunction

Methods: This study is a double randomized clinical trial 34 CAD's patients with LV dysfunction were randomly selected by consecutive sampling methods from September November 2015 They were divided into two groups Sixteen patients were given 600 mg dose of allopurinol per oral one day before and 6 hours before surgery and the rest received placebo Complications of post CABG surgery were observed since the aortic cross clamp off until discharged

Results: The use of post surgery inotropic and IABP found significantly lower in allopurinol group p 0 047 There was no significant difference in proportion of death in post operative hospitalization period in both groups 6 25 vs 5 6 p 1 000 While for the incidence of arrhythmias was found significantly different in the two groups 31 vs 66 p 0 039 with atrial fibrillation as the most common arrhythmia No perioperative myocardial infarction was found in this study therefore effects of allopurinol to the event is unknown

Conclusions: Pre operative administration of allopurinol may reduce the complications of post CABG especially the use of inotropic and IABP and occurrence of arrhythmias"